Table 3.
Six patients with the development of repermeabilized vein, other collaterals other than left gastric vein, following balloon-occluded retrograde transvenous obliteration.
| Case | Age (years)/ Gender | Hemoglobin (g/dL) | Platelet Counts (×104/mm3) | AST (IU/L) | ALT (IU/L) | Creatinine (mg/dL) | Child-Pugh A/B/C (Score) | HCC (±) | |
| 1 | 53/male | 5.7 | 8 | 37 | 40 | 0.79 | B-7 | + | |
| 2 | 63/male | 13.6 | 6.9 | 57 | 45 | 0.49 | A-6 | + | |
| 3 | 64/female | 9.3 | 10.6 | 31 | 24 | 0.7 | A-5 | + | |
| 4 | 51/male | 13.8 | 8.1 | 51 | 27 | 0.67 | A-6 | − | |
| 5 | 63/female | 8.8 | 10.5 | 56 | 36 | 0.35 | A-5 | + | |
| 6 | 78/male | 14 | 16.5 | 71 | 57 | 1.12 | A-6 | − | |
| Case | GV Form | EV Form | Etiology | LGV > 3.55 mm | LGV Group (yes/no) |
Esophageal Varices
Exacerbation (yes/no) |
Repermeabilized
Vein (±) |
Other Collaterals than LGV |
Occurrence
Following BRTO (months) |
| 1 | F3 | F1 | HBV | 5.68 | Yes | No | + | - | 9 |
| 2 | F2 | F2 | HCV | 5.45 | Yes | Yes | + | - | 26 |
| 3 | F2 | F1 | HCV | 2.56 | No | Yes | + | Inferior mesenteric vein | 8 |
| 4 | F2 | F1 | NBNC | 2.55 | No | Yes | - | Spleno-renal shunt | 5 |
| 5 | F3 | F1 | NBNC | 3.34 | No | No | - | Abdominal wall veins | 24 |
| 6 | F2 | F0 | Alcohol | 5.61 | Yes | No | - | Paraumbilical vein | 36 |
AST—aspartate aminotransferase; ALT—alanine aminotransferase; HCC—hepatocellular carcinoma; GV—gastric varices; EV—esophageal varices; HBV—hepatitis B virus; HCV—hepatitis C virus; NBNC—non-HBV, non-HCV; LGV—left gastric vein.